Medicare Covers GLP-1 Weight-Loss Drugs Starting July 1
Qualifying Medicare beneficiaries can access GLP-1 weight-loss drugs for $50/month beginning July 1. Here's what older Americans must weigh first.
Big news if you're on Medicare: starting July 1, you could get your hands on GLP-1 weight-loss drugs — think Ozempic and Wegovy territory — for just $50 a month. That's a massive shift. These meds were previously out of reach for most Medicare enrollees seeking weight loss coverage, and the out-of-pocket costs without insurance were brutal.
But before you call your doctor, slow down. Not every Medicare beneficiary qualifies. You'll need to meet specific eligibility criteria to tap into this benefit, so confirm your status before you start counting on that $50 price tag. This isn't a blanket rollout for every senior on the program.
Read more SEED OK Gave Newborns $1,000 Before Trump Accounts Existed →
Here's the part nobody wants to talk about: side effects are real. GLP-1 drugs are powerful, and older adults face unique risks. Muscle loss is a serious concern — and for seniors, losing muscle mass isn't just a cosmetic issue. It can affect mobility, balance, and your ability to stay independent. That's a tradeable risk you need to price in before starting therapy.
The smart move is a candid conversation with your physician about whether the weight-loss benefit outweighs the physical risks at your age and health status. Pair any GLP-1 regimen with resistance training and adequate protein intake to protect muscle. The $50 price point is compelling, but your long-term health is the real position you're managing here.
Continue reading at MarketWatch.com
